HERNAN VALDEZ, MD
Osteopathic Medicine at Selwyn Ave, Bronx, NY
License number
New York 232013
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2
1650 Selwyn Ave FL 9, Bronx, NY 10457
20 E 35Th St APT 8M, New York, NY 10016
20 E 35Th St APT 8M, New York, NY 10016
Phone
(718) 960-1020
(718) 960-2033 (Fax)
(646) 672-9811
(718) 960-2033 (Fax)
(646) 672-9811
Personal information
See more information about HERNAN VALDEZ at radaris.comName
Address
Phone
20 E 35Th St APT 8M, New York, NY 10016
5214 103Rd St, Corona, NY 11368
140 Harding Ave, White Plains, NY 10606
377 33Rd St, Manhattan, NY 10016
446 Acorn Hill Rd, Olivebridge, NY 12461
Organization information
See more information about HERNAN VALDEZ at bizstanding.comHernan Valdez MD
1650 Grand Concourse, Bronx, NY 10457
Industry:
Internist
Phone:
(718) 590-1800 (Phone)
Hernan Valdez
Professional information
Dr. Hernan Valdez, Bronx NY - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
1650 Selwyn Ave, Bronx 10457
(718) 960-1020 (Phone), (718) 960-2033 (Fax)
(718) 960-1020 (Phone), (718) 960-2033 (Fax)
Certifications:
Infectious Disease, 2006, Internal Medicine, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1650 Selwyn Ave, Bronx 10457
University Hospitals Case Medical Center
11100 Euclid Ave, Cleveland 44106
University Hospitals Case Medical Center
11100 Euclid Ave, Cleveland 44106
Education:
Medical School
Universidad Peruana Cayetano Heredia, Facultad De Medicina Alberto Hurtado
Graduated: 1990
Henry Ford Hospital
Graduated: 1992
Graduated: 1994
University Hosps
Universidad Peruana Cayetano Heredia, Facultad De Medicina Alberto Hurtado
Graduated: 1990
Henry Ford Hospital
Graduated: 1992
Graduated: 1994
University Hosps
Medical Director At Pfizer
Position:
medical director at pfizer
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
pfizer
-
medical director
Education:
Universidad Peruana Cayetano Heredia 1982 - 1989
Combination Therapy Comprising A Ccr5 Antagonist, A Hiv-1 Protease Inhibtior And A Pharmacokinetic Enhancer
US Patent:
2013002, Jan 24, 2013
Filed:
Mar 30, 2011
Appl. No.:
13/638999
Inventors:
Randy Tressler - Forest Hill MD, US
Hernan Valdez - New York NY, US
Hernan Valdez - New York NY, US
International Classification:
A61K 31/675, A61P 31/14, A61K 31/427, A61P 31/18, A61K 31/439, A61K 31/4402
US Classification:
514 81, 514304, 514357, 514365
Abstract:
The present invention discloses a novel combination therapy for HIV-1 treatment relying on a combination of at least one CCR5 antagonist, at least one HIV-1 protease inhibitor and at least one pharmacokinetic enhancer of said at least one CCR5 antagonist and/or at least one HIV-1 protease inhibitor. The combination is intended for use in oral treatment of a disorder selected from the group consisting of HIV-1 infection, retroviral infections genetically related to HIV and AIDS, in a treatment-naïve patient infected with CCR5 tropic HIV-1 virus.
Hernan Valdez
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Hernan Valdez
Location:
Greater New York City Area
Industry:
Pharmaceuticals